3rd Annual Inhalation & Respiratory Drug Delivery USA Congress

Start Date : March 17, 2020
End Date : March 18, 2020
Time : 7:30 am to5:00 pm

Phone : 01865248455
Email : e.hawkings@oxfordglobal.co.uk

Location :
Hilton San Diego Mission Valley, 901 Camino del Rio South, 92108, San Diego, United States



Join us to hear about the latest industry innovations at Oxford Global's Inhalation and Respiratory Drug Delivery USA Congress, 17 - 18 March 2020 in San Diego.


Over 300 delegates from the inhalation, formulation and drug delivery industry representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and research institutions.


Over 20 presentations and case studies focussing on the emerging therapies and key issues in inhalation and respiratory drug delivery as well as the latest developments in medical devices and digital health products.


Including 2 interactive streams:


- Development and Formulation of Inhaled Therapies

- Inhalation Devices and Analytics


This event is co-located with the 3rd Annual Formulation and Drug Delivery USA Congress


For more information, please contact e.hawkings@oxfordglobal.co.uk


Go Social: Join our Formulation and Drug Delivery Network on LinkedIn, follow us on Twitter @FDDCongress and join the conversation at #FDDUS19


*2020 Live Webinar*

'The Design And Development Of A Connected Inhalation System To Help With Monitoring And Patient Adherence'

Hosted by Paul Upham, Head, Smart Devices, Genentech

Wed, Jan 15, 2020 4:30 PM - 5:30 PM GMT

Register for Free: https://bit.ly/2kK3BqB


Brochure: https://go.evvnt.com/525538-3?pid=3506


Speakers: Christy Cappelletti, Director, Clinical Development, AstraZeneca, Yaping Zhu, Executive Director, Device Development & Inhalation Development, Sandoz, George Cusatis, Associate Director, Device & Digital Health, Merck, Samir Shah, Associate Director, Respiratory and Combination Regulatory Affairs, Teva, Paul Upham, Head, Smart Devices, Genentech, Larry Brown, Chief Scientific Officer & Executive Vice President, Noveome, Carlos Schuler, Chief Operating and Technical Officer, InCarda Therapeutics, Stephen Pham, Vice President Product Development, Avalyn Pharma

Registration Info

Register Now


Registration Available from: USD 720.00

Organized by

Organized by LoveEvvnt1

Oxford Global

Your Review

You must be logged in to post a comment.